MedTrace Logo

Low-dose Protocol for Computed Tomography-guided Lung Biopsy

NCT02971176 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2019-06-04

No results posted yet for this study

Summary

The purpose of this study is to compare the diagnostic accuracy and complication rate between low-dose computed tomography-guided and standard-dose computed tomography-guided lung biopsy.

Conditions

  • Lung Cancer, Adenocarcinoma
  • Lung Inflammatory Pseudotumor

Interventions

RADIATION

Low-dose protocol computed tomography

Radiation dose under the low-dose protocol computed tomography (120 kilovolt, 15 milliampere seconds)

RADIATION

Standard-dose protocol computed tomography

Radiation dose under the standard-dose protocol computed tomography (120 kilovolt, 150 milliampere seconds)

Sponsors & Collaborators

  • Xuzhou Central Hospital

    lead OTHER

Principal Investigators

  • Zi-Qi Tao, MD · Science and Education Division of Xuzhou Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02971176 on ClinicalTrials.gov